Search Results

There are 12578 results for: content related to: An observational study of the effectiveness and safety of intramuscular olanzapine in the treatment of acute agitation in patients with bipolar mania or schizophrenia/schizoaffective disorder

  1. You have free access to this content
    Olanzapine: Preclinical and Clinical Profiles of a Novel Antipsychotic Agent

    CNS Drug Reviews

    Volume 6, Issue 4, December 2000, Pages: 303–363, Gary D. Tollefson and Cindy C. Taylor

    Article first published online : 7 JUN 2006, DOI: 10.1111/j.1527-3458.2000.tb00155.x

  2. Olanzapine in Treatment for Bipolar Disorder

    Bipolar Psychopharmacotherapy: Caring for the Patient, Second Edition

    Mauricio Tohen, Giedra Campbell, Juan-Carlos Gómez, Pages: 79–107, 2011

    Published Online : 13 APR 2011, DOI: 10.1002/9780470975114.ch6

  3. Pharmacokinetics and tissue distribution of olanzapine in rats

    Biopharmaceutics & Drug Disposition

    Volume 20, Issue 8, November 1999, Pages: 369–377, Manickam Aravagiri, Yaroslav Teper and Stephen R. Marder

    Article first published online : 22 JUN 2000, DOI: 10.1002/1099-081X(199911)20:8<369::AID-BDD200>3.0.CO;2-6

  4. Olanzapine in Treatment for Bipolar Disorder

    Bipolar Psychopharmacotherapy: Caring for the Patient

    Mauricio Tohen, Giedra Campbell, Daniel Lin, Pages: 85–103, 2006

    Published Online : 31 MAY 2006, DOI: 10.1002/0470017953.ch6

  5. You have free access to this content
    Interactions between valproic acid and quetiapine/olanzapine in the treatment of bipolar disorder and the role of therapeutic drug monitoring

    Journal of Pharmacy and Pharmacology

    Volume 66, Issue 6, June 2014, Pages: 747–759, Thomas Vella and Janet Mifsud

    Article first published online : 7 JAN 2014, DOI: 10.1111/jphp.12209

  6. You have free access to this content
    Hormonal and Metabolic Effects of Olanzapine and Clozapine Related to Body Weight in Rodents

    Obesity

    Volume 14, Issue 1, January 2006, Pages: 36–51, Vance L. Albaugh, Cathy R. Henry, Nicholas T. Bello, Andras Hajnal, Susan L. Lynch, Beth Halle and Christopher J. Lynch

    Article first published online : 6 SEP 2012, DOI: 10.1038/oby.2006.6

  7. You have full text access to this OnlineOpen article
    Antipsychotics inhibit glucose transport: Determination of olanzapine binding site inStaphylococcus epidermidis glucose/H+ symporter

    FEBS Open Bio

    Volume 5, Issue 1, January 01, 2015, Pages: 335–340, Petr Babkin, Alayna M. George Thompson, Cristina V. Iancu, D. Eric Walters and Jun-yong Choe

    Article first published online : 15 APR 2015, DOI: 10.1016/j.fob.2015.04.006

  8. Olanzapine alone or in combination for acute mania

    Intervention Review

    The Cochrane Library

    Jennifer M Rendell, Harm J Gijsman, Paul K Keck, Guy Goodwin and John Geddes

    Published Online : 20 JAN 2003, DOI: 10.1002/14651858.CD004040

  9. Olanzapine versus other atypical antipsychotics for schizophrenia

    Intervention Review

    The Cochrane Library

    Katja Komossa, Christine Rummel-Kluge, Heike Hunger, Franziska Schmid, Sandra Schwarz, Lorna Duggan, Werner Kissling and Stefan Leucht

    Published Online : 17 MAR 2010, DOI: 10.1002/14651858.CD006654.pub2

  10. Olanzapine in long-term treatment for bipolar disorder

    Intervention Review

    The Cochrane Library

    Andrea Cipriani, Jennifer M Rendell and John Geddes

    Published Online : 21 JAN 2009, DOI: 10.1002/14651858.CD004367.pub2

  11. Olanzapine increases hepatic glucose production through the activation of hypothalamic adenosine 5′-monophosphate-activated protein kinase

    Diabetes, Obesity and Metabolism

    Volume 15, Issue 12, December 2013, Pages: 1128–1135, M. Ikegami, H. Ikeda, T. Ohashi, M. Ohsawa, Y. Ishikawa, M. Kai, A. Kamei and J. Kamei

    Article first published online : 11 JUL 2013, DOI: 10.1111/dom.12148

  12. You have free access to this content
    Safety and efficacy of olanzapine in the long-term treatment of Japanese patients with bipolar I disorder, depression: An integrated analysis

    Psychiatry and Clinical Neurosciences

    Volume 68, Issue 7, July 2014, Pages: 498–505, Hideaki Katagiri, Mauricio Tohen, David P. McDonnell, Shinji Fujikoshi, Michael Case, Shigenobu Kanba, Michihiro Takahashi and Juan-Carlos Gomez

    Article first published online : 4 MAR 2014, DOI: 10.1111/pcn.12156

  13. Lack of Pharmacokinetic Interaction Between Lamotrigine and Olanzapine in Healthy Volunteers

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 26, Issue 5, May 2006, Pages: 627–633, Dr. Michael W. Jann, Dr. Yuen Yi Hon, Dr. Shahab A. Shamsi, Dr. Jack Zheng, Dr. Eric A. Awad and Dr. Vicky Spratlin

    Article first published online : 6 JAN 2012, DOI: 10.1592/phco.26.5.627

  14. Plasma concentrations of high-dose olanzapine in a double-blind crossover study

    Human Psychopharmacology: Clinical and Experimental

    Volume 21, Issue 6, August 2006, Pages: 393–398, Deanna L. Kelly, Charles M. Richardson, Yang Yu and Robert R. Conley

    Article first published online : 19 JUL 2006, DOI: 10.1002/hup.781

  15. Olanzapine Transfer By Human Placenta

    Clinical and Experimental Pharmacology and Physiology

    Volume 26, Issue 9, September 1999, Pages: 691–697, S Schenker, Y Yang, E Mattiuz, D Tatum and M Lee

    Article first published online : 24 DEC 2001, DOI: 10.1046/j.1440-1681.1999.03111.x

  16. You have free access to this content
    The effect of ethinylestradiol-containing contraceptives on the serum concentration of olanzapine and N-desmethyl olanzapine

    British Journal of Clinical Pharmacology

    Volume 71, Issue 4, April 2011, Pages: 611–615, Tore Haslemo, Helge Refsum and Espen Molden

    Article first published online : 11 MAR 2011, DOI: 10.1111/j.1365-2125.2010.03880.x

  17. Olanzapine for schizophrenia

    Intervention Review

    The Cochrane Library

    Lorna Duggan, Mark Fenton, John Rathbone, Roland Dardennes, Ahmed El-Dosoky and Saroja Indran

    Published Online : 20 APR 2005, DOI: 10.1002/14651858.CD001359.pub2

  18. UGT1A4*3 Encodes Significantly Increased Glucuronidation of Olanzapine in Patients on Maintenance Treatment and in Recombinant Systems

    Clinical Pharmacology & Therapeutics

    Volume 92, Issue 2, August 2012, Pages: 221–227, T Haslemo, I Loryan, N Ueda, B Mannheimer, L Bertilsson, M Ingelman-Sundberg, E Molden and E Eliasson

    Article first published online : 20 JUN 2012, DOI: 10.1038/clpt.2012.46

  19. Characterization of olanzapine (LY170053) in human liver slices by liquid chromatography/tandem mass spectrometry

    Journal of Mass Spectrometry

    Volume 33, Issue 12, December 1998, Pages: 1237–1245, A. T. Murphy, B. G. Lake, J. R. Bernstein, R. B. Franklin and T. A. Gillespie

    Article first published online : 5 JAN 1999, DOI: 10.1002/(SICI)1096-9888(199812)33:12<1237::AID-JMS742>3.0.CO;2-F

  20. Dose-Dependent Alternations in the Pharmacokinetics of Olanzapine During Coadministration of Fluvoxamine in Patients With Schizophrenia

    The Journal of Clinical Pharmacology

    Volume 44, Issue 12, December 2004, Pages: 1385–1390, Dr Chih-Chiang Chiu, Dr Hsien-Yuan Lane, Dr Ming-Chyi Huang, Dr Hui-Ching Liu, Dr Michael W. Jann, Dr Yuen-Yi Hon, Dr Wen-Ho Chang and Dr Mong-Liang Lu

    Article first published online : 8 MAR 2013, DOI: 10.1177/0091270004270291